RELMADA THERAPEUTICS, INC. Letters of Credit Outstanding, Amount
RELMADA THERAPEUTICS, INC. (RLMD) had Letters of Credit Outstanding, Amount of $390.80 thousand as of 2016-03-31, per its 10-Q filed 2016-05-09.
Discontinued › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2016-05-09
- 2016-03-31: Letters of Credit Outstanding, Amount $390.80K.
- 2015-12-31: Letters of Credit Outstanding, Amount $390.80K.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2016-03-31 | $390.80K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $390.80K 10-Q · filed 2016-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |